The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000670370p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
17/05/2026
Date registered
Help: Date registered
5/06/2026
Date last updated
Help: Date last updated
5/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
5/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
A comparison between parecoxib and Maxigesic for pain relief post elective caesarean section. A three-armed single-blinded randomised study
Scientific title
Parecoxib vERsus maxigesic For analgesia post Elective Caesarean secTion. A three-armed single-blinded randomised trial pilot study
Additional trial identifiers [1] 317317 0
Nil
Universal Trial Number (UTN)
Trial acronym
The PERFECT Study
Related trial records

Health condition
Health condition(s) studied:
Elective caesarean section 341962 0
Condition category
Condition code
Reproductive Health and Childbirth 338037 338037 0 0
Childbirth and postnatal care
Surgery 338182 338182 0 0
Other surgery

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention A: Intraoperative IV 40 mg parecoxib and IV 1g paracetamol is administered by the attending anaesthetist. Parecoxib is a lyophilised powder that is reconstituted with 5 ml normal saline. Paracetamol is provided as 1000 mg in 100 ml solution for infusion. Postoperative regular oral paracetamol 1 g every 6 hours and regular oral ibuprofen 400 mg every 8 hours, with the first dose of oral ibuprofen being given no less than 12 hours post IV parecoxib, is administered by the midwife caring for the participant. Paracetamol and ibuprofen are supplied as tablets.

Intervention B: Intaoperative IV Maxegisic (combination 1 g paracetamol/300 mg ibuprofen) in 100 ml solution for infusion is administerd by the attending anaesthetist. Postoperative regular oral Maxegisic (combination 500 mg paracetamol/150 mg ibuprofen), two tablets, every 6 hours is administered by the midwife caring for the participant..

Intervention C: Intraoperative IV 40 mg parecoxib and IV 1 g paracetamol. Postoperative two tablets of Maxigesic, with the first dose being given no less than 12 hours post IV parecoxib
Intervention code [1] 334095 0
Prevention
Intervention code [2] 334096 0
Treatment: Drugs
Description of the comparator or control
Although all of the interventions will be compared to each other, the comparator is intervention A, which consists of IV parecoxib (40 mg) and IV paracetamol (1 g), followed by regular oral paracetamol (500 mg) x 2 tablets q6H and regular ibuprofen (200 mg) x 2 tablets q8H, with the first dose of regular ibuprofen commencing 12 hours after the IV administeration of 40 mg parecoxib intraoperatively.
Control group
Active

Outcomes
Primary outcome [1] 345443 0
The total pain score as determined by the Short Form McGill Pain Questionnaire
Timepoint [1] 345443 0
The total pain score will be determined separately on days 1 and 2 post elective caesarean section
Secondary outcome [1] 461697 0
Pain score component of the Short Form McGill Pain Questionnaire
Timepoint [1] 461697 0
The summation of the pain scores for the Short Form McGill Pain Questionnaire will be determined on days 1 and 2 post elective caesarean section
Secondary outcome [2] 461698 0
The Visual analgoue score (VAS) as part of the overall Short From McGill Pain Questionnaire
Timepoint [2] 461698 0
The VAS pain score (defined in mm of length of a horizontal line anchored at one end with "no pain" and the other end "worst possible pain" will be determined on days 1 and 2 post elective caesarean section
Secondary outcome [3] 461699 0
The Present Pain Intensity (PPI) score as part of the overall Short From McGill Pain Questionnaire.
Timepoint [3] 461699 0
The PPI pain score will be determined on days 1 and 2 post elective caesarean section
Secondary outcome [4] 461700 0
Total oxycodone consumed (mg)
Timepoint [4] 461700 0
On discharge from the hospital or the completion of day 2 post elective caesarean section, whichever occurs first.
Secondary outcome [5] 461701 0
Total paracetamol consumed (g)
Timepoint [5] 461701 0
On discharge from the hospital or the completion of day 2 post elective caesarean section, whichever occurs first.
Secondary outcome [6] 461702 0
Total ibuprofen consumed (mg)
Timepoint [6] 461702 0
On discharge from the hospital or the completion of day 2 post elective caesarean section, whichever occurs first.
Secondary outcome [7] 462132 0
Worst pain experienced since the spinal anaesthesia wore off, as part of the Short Form McGill Pain Qeustionnaire
Timepoint [7] 462132 0
The worst pain score since the spinal anaesthesia wore off will be determined on days 1 and 2 post elective caesarean section

Eligibility
Key inclusion criteria
All women with a singleton pregnancy presenting to The Northern Hospital who have consented to undergo an elective caesarean section
Minimum age
18 Years
Maximum age
50 Years
Sex
Females
Healthy volunteers
No
Key exclusion criteria
Age < 18 years old
Pregnant women who do not have the legal and/or mental capacity to consent
Multiple gestation
A contraindication to the use of a NSAID (parecoxib or ibuprofen)
Women who have signed the study information brochure electing to opt out participation with the McGill Short Form Pain Questionnaire

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation using the REDCap database
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by computer generated random numbers in blocks of six and nine
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Parallel
Other design features
Phase
Phase 4
Type of endpoint/s
Efficacy
Statistical methods / analysis
Statistics will be presented using tables, graphs and descriptive statistics. No loss to follow-up is expected at the time of primary outcome total pain score on days 1 and 2 post elective caesarean section and missing data in secondary outcomes are expected to be negligible. No crossovers between the randomised interventions are anticipated.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29528 0
The Northern Hospital - Epping
Recruitment postcode(s) [1] 45846 0
3076 - Epping

Funding & Sponsors
Funding source category [1] 321884 0
Hospital
Name [1] 321884 0
Northern Health
Country [1] 321884 0
Australia
Primary sponsor type
Individual
Name
Dr Darren Lowen, Northern Health
Address
Country
Australia
Secondary sponsor category [1] 324746 0
None
Name [1] 324746 0
Address [1] 324746 0
Country [1] 324746 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320423 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 320423 0
Ethics committee country [1] 320423 0
Australia
Date submitted for ethics approval [1] 320423 0
01/07/2026
Approval date [1] 320423 0
Ethics approval number [1] 320423 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150438 0
Dr Darren Lowen
Address 150438 0
Department of Anaesthesia, Perioperative Medicine & Pain, The Northern Hospital, 185 Cooper Street, Epping, VIC, 3076
Country 150438 0
Australia
Phone 150438 0
+61 402 832 336
Fax 150438 0
Email 150438 0
Contact person for public queries
Name 150439 0
Darren Lowen
Address 150439 0
Department of Anaesthesia, Perioperative Medicine & Pain, The Northern Hospital, 185 Cooper Street, Epping, VIC, 3076
Country 150439 0
Australia
Phone 150439 0
+61 402 832 336
Fax 150439 0
Email 150439 0
Contact person for scientific queries
Name 150440 0
Darren Lowen
Address 150440 0
Department of Anaesthesia, Perioperative Medicine & Pain, The Northern Hospital, 185 Cooper Street, Epping, VIC, 3076
Country 150440 0
Australia
Phone 150440 0
+61 402 832 336
Fax 150440 0
Email 150440 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• In addition to institutional policy with regards to release of data , data will be made available subject to approval by the principal investigator, via e-mail address: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.